Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell-mediated antitumor immunity.
Ren X, Peng M, Xing P, Wei Y, Galbo PM Jr, Corrigan D, Wang H, Su Y, Dong X, Sun Q, Li Y, Zhang X, Edelmann W, Zheng D, Zang X.
Ren X, et al.
J Clin Invest. 2022 Nov 15;132(22):e163620. doi: 10.1172/JCI163620.
J Clin Invest. 2022.
PMID: 36377656
Free PMC article.